Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 13

1.

BEta versus Gamma Utrecht Trial-Cypher (BEGUT-CYPHER): Is intracoronary brachytherapy still superior to drug-eluting stents?

Stella PR, de Jaegere P, Battermann JJ, Bouma P, Moerland MA, Doevendans PA.

Neth Heart J. 2004 Sep;12(9):389-393.

2.

Switching types of drug-eluting stents does not prevent repeated in-stent restenosis in patients with coronary drug-eluting stent restenosis.

Nojima Y, Yasuoka Y, Kume K, Adachi H, Hattori S, Matsutera R, Kohama Y, Sasaki T.

Coron Artery Dis. 2014 Dec;25(8):638-44. doi: 10.1097/MCA.0000000000000159.

3.

Intracoronary radiation therapy: an evidence-based analysis.

Health Quality Ontario..

Ont Health Technol Assess Ser. 2001;1(1):1-36. Epub 2001 Dec 1. No abstract available.

4.

Drug-eluting stent as an option for intractable in-stent coronary restenosis.

Hachinohe D, Jeong MH, Kim MC, Cho KH, Ahmed K, Hwang SH, Lee MG, Sim DS, Park KH, Kim JH, Hong YJ, Ahn Y, Kang JC.

Korean Circ J. 2011 Nov;41(11):677-80. doi: 10.4070/kcj.2011.41.11.677. Epub 2011 Nov 29.

5.

Long term outcome after intracoronary beta radiation therapy.

Sianos G, Hoye A, Saia F, van der Giessen W, Lemos P, de Feyter PJ, Levendag PC, van Domburg R, Serruys PW.

Heart. 2005 Jul;91(7):942-7.

6.

The long-term clinical results of a platelet glycoprotein IIb/IIIa receptor blocker (Abciximab: Reopro) coated stent in patients with coronary artery disease.

Kim W, Jeong MH, Hong YJ, Lee SH, Park WS, Kim JH, Kim IS, Choi MJ, Ahn YK, Cho JG, Park JC, Cho DL, Kim H, Kang JC.

Korean J Intern Med. 2004 Dec;19(4):220-9.

7.

Intracoronary brachytherapy for the treatment of complex in-stent restenosis.

Cotton JM, Rance K, Patil A, Thomas MR.

Heart. 2005 Feb;91(2):231-2. No abstract available.

8.

A novel method of brachytherapy using local delivery of 99mTc-HMPAO for coronary stent restenosis.

Kim W, Jeong MH, Kim SH, Park WS, Park OY, Kim JH, Bom HS, Jeong HJ, Ahn YK, Cho JG, Park JC, Kang JC.

Korean J Intern Med. 2004 Sep;19(3):179-88.

9.

Routine sirolimus eluting stent implantation for unselected in-stent restenosis: insights from the rapamycin eluting stent evaluated at Rotterdam Cardiology Hospital (RESEARCH) registry.

Saia F, Lemos PA, Arampatzis CA, Hoye A, Degertekin M, Tanabe K, Sianos G, Smits PC, van der Giessen WJ, de Feyter PJ, van Domburg RT, Serruys PW.

Heart. 2004 Oct;90(10):1183-8.

10.

Regulation of vascular smooth muscle cell growth: targeting the final common pathway.

Taylor AM, McNamara CA.

Arterioscler Thromb Vasc Biol. 2003 Oct 1;23(10):1717-20. No abstract available.

11.

The Proliferation REduction with Vascular ENergy Trial (PREVENT).

Raizner AE, Kaluza GL.

Curr Control Trials Cardiovasc Med. 2001;2(1):16-19.

12.

Long-term outcome after coronary stenting.

Kastrati A, Hall D, Schömig A.

Curr Control Trials Cardiovasc Med. 2000;1(1):48-54.

13.

Supplemental Content

Support Center